Get the Stockscreener App
6.495
1.14%
-0.075
After Hours:
6.57
0.075
+1.15%
Immucell Corp stock is traded at $6.495, with a volume of 19,760.
It is down -1.14% in the last 24 hours and up +16.61% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.57
Open:
$6.6
24h Volume:
19,760
Relative Volume:
0.77
Market Cap:
$58.75M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-12.99
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
+9.71%
1M Performance:
+16.61%
6M Performance:
-3.78%
1Y Performance:
+25.63%
1-Day Range:
$6.495
$6.8921
1-Week Range:
$5.80
$6.8921
52-Week Range:
$4.28
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.495 | 59.43M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immucell Corp Stock (ICCC) Latest News
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement - Investing.com
Is ImmuCell Corporation stock resilient to inflationQuarterly Trade Summary & Precise Trade Entry Recommendations - ulpravda.ru
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense - Investing.com
Macro Review: Is ImmuCell Corporation stock near bottom after declineJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - ulpravda.ru
How rising interest rates impact ImmuCell Corporation stockCPI Data & Daily Market Momentum Tracking - ulpravda.ru
Will ImmuCell Corporation stock maintain dividend yieldJuly 2025 Short Interest & Trade Opportunity Analysis Reports - ulpravda.ru
ImmuCell Corporation Announces Investor Conference Call to Discuss Strategic Shift and Q4 2025 Sales Results - Quiver Quantitative
Cattle firm ImmuCell shifts focus to calf product, previews 2025 sales - Stock Titan
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - Stocktwits
ImmuCell Puts Re-Tain On Pause After FDA Letter - Benzinga
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Top Stock Reports for AbbVie, Coca-Cola & Chevron - sharewise.com
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain By Investing.com - Investing.com South Africa
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain - Investing.com
ImmuCell Corporation Receives Incomplete FDA Letter for Re-Tain® NADA and Expands First Defense® Sales Force by 50% - Quiver Quantitative
How a $900M calf-health market is reshaping this Maine animal company - Stock Titan
Will ImmuCell Corporation stock outperform Dow Jones indexJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Улправда
Why ImmuCell Corporation stock is popular among millennialsQuarterly Market Review & Long-Term Capital Growth Strategies - Улправда
Can ImmuCell Corporation stock maintain operating marginsPortfolio Growth Summary & High Return Trade Guides - ulpravda.ru
ImmuCell Corporation's (NASDAQ:ICCC) Price Is Right But Growth Is Lacking After Shares Rocket 34% - simplywall.st
ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
ImmuCell (NASDAQ:ICCC) delivers shareholders 27% return over 1 year, surging 13% in the last week alone - simplywall.st
Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth - Finviz
Bull Run: Will ImmuCell Corporation stock maintain dividend yieldTrade Risk Report & Weekly Hot Stock Watchlists - moha.gov.vn
Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
ImmuCell Corp President and CEO Acquires 9,785 Shares - TradingView — Track All Markets
Will ImmuCell Corporation stock continue dividend increasesMarket Sentiment Summary & Verified Technical Trade Signals - Newser
Will ImmuCell Corporation stock deliver consistent dividends2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Is ImmuCell Corporation (IUL) stock a buy before earnings resultsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Is ImmuCell Corporation (IUL) stock a fit for income portfoliosJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 By Investing.com - Investing.com Canada
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 - Investing.com
ImmuCell Corp Director David Scott Tomsche Buys Shares - TradingView
Chmn Tomsche Buys 3,266 ($15.6K) Of Immucell Corp [ICCC] - TradingView
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Will ImmuCell Corporation stock sustain high P E ratiosM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength - Yahoo Finance
Why ImmuCell Corporation stock is a must watch in 2025Trade Risk Report & Daily Profit Maximizing Tips - newser.com
Will ImmuCell Corporation bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
How to monitor ImmuCell Corporation with trend dashboards2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
ImmuCell Corporation (NASDAQ:ICCC) Q3 2025 Earnings Call Transcript - Insider Monkey
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):